Medical marijuana is reshaping Parkinson’s care, as a new survey shows patients widely adopting the therapy and experiencing measurable symptom relief.
Survey highlights
The Michael J. Fox Foundation’s Fox Insight survey collected responses from 1,900 people living with Parkinson’s disease.
Seventy percent of participants reported using medical marijuana and many noted improvements in sleep, anxiety and pain.
Thirteen percent were uncertain which product they used, while 30 percent never discussed the therapy with their physician.
Implications for care
These firsthand insights give researchers, clinicians and advocates concrete data to shape future treatment guidelines and drive evidence‑based policy.
Patients can download a free guide on medical marijuana and Parkinson’s and watch an accompanying webinar to learn how the therapy is applied in practice.
Support and editorial integrity
The Ask the MD program operates under the leadership of the Parkinson’s Disease Education Consortium and the Albert B. Glickman Parkinson’s Disease Education Program.
These partners enable high‑quality educational content while the Michael J. Fox Foundation retains full editorial control, ensuring donor funds prioritize high‑impact research.
